Global Tissue Diagnostics Market 2019-2022 | 6.9% CAGR Projection over the Next Five Years

The stronga data-cke-saved-href="https://www.marketsandmarkets.com/Market-Reports/tissue-diagnostics-market-1063949.html" href="https://www.marketsandmarkets.com/Market-Reports/tissue-diagnostics-market-1063949.html"tissue diagnostics market/a/strong is expected to reach USD 5.14 Billion by 2022 from USD 3.44 Billion in 2016 at a CAGR of 6.9%./ppFactors driving the growth of this market include the rising incidence of cancer, growing healthcare expenditure, improving infrastructure for cancer diagnosis, and technological advancements in tissue diagnostics./ppIn this report, the Tissue Diagnostics market has been segmented based on product, technology, disease, end user, and region./ppstrongWhat the Market Looks Like?/strong/ppThe Report "strongTissue Diagnostics Market by Product (Consumables, Instruments), Technology (Immunohistochemistry, in Situ Hybridization, Digital Pathology & Workflow), Disease (Breast Cancer, Gastric Cancer, Lymphoma), End User (Hospital, CRO) - Global Forecast to 2022/strong"/ppstrongDownload a FREE Pdf Brochuer@:- a href="/strongstronga data-cke-saved-href=" https:="" www.marketsandmarkets.com="" pdfdownloadnew.asp?id="1063949"" style="text-decoration-line: underline;">https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1063949">https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1063949

Consumables are estimated to account for the largest market share in 2017

By product, the tissue diagnostics market is classified into instruments and consumables. The consumables segment is expected to lead the global tissue diagnostics market in 2017. Factors driving the growth of this segment include the wide use of consumables for processing tissue samples, ease of use, and cost-effectiveness.

The immunohistochemistry segment is expected to dominate the market in 2017

By technology, the market is segmented into immunohistochemistry, in situ hybridization, digital pathology and workflow, and special staining. The immunohistochemistry technology segment is expected to account for the largest share of the global tissue diagnostics market in 2017. A large number of products are based on this technology which is a major factor responsible for the dominant share of this segment.

The Major Players Opearting in the Tissue Diagnostics Market:

Key players in the Tissue Diagnostics Market include Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott (US), Agilent Technologies (US), Merck (Germany), Sakura Finetek Japan (Japan), Abcam (UK), BD (US), QIAGEN (Netherlands), Sienna Cancer Diagnostics (Australia), Royal Philips (Netherlands), A. Menarini Diagnostics (Italy), Cell Signaling Technology (US), Enzo Life Sciences (US), Master Diagnóstica (Spain), TissueGnostics (Austria), Bio SB (US), MedImmune (US), Cernostics (US), Zenalux Biomedical (US), 3DHISTECH (Hungary), Lunaphore Technologies (Switzerland), BioGenex (US), and Biocare Medical (US).

Get a FREE Request Sample Report@:-https://www.marketsandmarkets.com/requestsampleNew.asp?id=9571619

Geographical Detailed Analysis for Tissue Diagnostics Market:

The global tissue diagnostics market is dominated by North America, followed by Europe.

North America will continue to dominate the global market during the forecast period. However, Asia is expected to witness the highest CAGR during the forecast period with growth centered at Japan, China, and India. Factors such as the rising focus of major players in emerging Asian countries and government support are driving the growth of the market in this region.

About MarketsandMarkets™:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441

Email: sales@marketsandmarkets.com

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche